About half of Americans strongly or somewhat favor having Medicare and Medicaid cover weight-loss drugs for people who have obesity, a recent AP-NORC poll showed, with about 2 in 10 opposed the idea and about one-quarter with a neutral view
Simple timing framework Baseline Discuss baseline labs before starting, especially with active injury, infection concern, liver disease, kidney disease, anemia, or copper metabolism concerns
The next phase of research is already underway: brain-penetrant GLP-1s, intranasal delivery, head-to-head neurocognitive trials, and combination approaches that pair metabolic repair with targeted neurobiology
Graves disease and Graves orbitopathy following COVID-19
Likewise, reestablished blood flow may certainly contribute to the rapid recovery effect noted